ValueAct raises stake in Horizon Discovery to nearly 10%
US activist investor snaps up shares in gene editing group from Neil Woodford
Source: FT.com - Drugs and Healthcare - Category: Pharmaceuticals Source Type: news
More News: Genetics | Pharmaceuticals